Valuation Metrics and Financial Ratios
At a price-to-earnings (PE) ratio of approximately 13.4, Vasundhara Rasy. trades at a moderate premium relative to many peers in its industry. Its price-to-book value stands at 1.71, indicating that the market values the company at nearly twice its book value. The enterprise value to EBITDA ratio of 14.8 further suggests a relatively elevated valuation, though not excessively so when compared to the broader pharmaceutical sector.
Return on capital employed (ROCE) and return on equity (ROE) are important indicators of operational efficiency and profitability. Vasundhara Rasy. posts a ROCE of 10.75% and an ROE of 12.74%, reflecting decent returns but not exceptional when benchmarked against industry leaders. The dividend yield of 1....
Read More






